Scientists test direct tumor injection in fight against tough cancers
NCT ID NCT05427487
Summary
This is an early-stage study testing the safety of a new treatment called IVX037, which is injected directly into tumors. It is for people with advanced colorectal, gastric, or ovarian cancer that has stopped responding to standard treatments. The study has two parts: first testing IVX037 alone, and then testing it in combination with an existing immunotherapy drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Melbourne Site
RECRUITINGMelbourne, Victoria, 3000, Australia
Contact
-
South Australia site
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact
-
Sydney site
RECRUITINGSydney, New South Wales, 2000, Australia
Contact
Conditions
Explore the condition pages connected to this study.